Clinical TrialsStructure Advances Oral Obesity Pipeline With ACCG-2671 and Aleniglipron Da... Structure Advances Oral Obesity Pipeline With ACCG-2671 and Aleniglipron Da... Read Post »
Clinical TrialsRedasemtide Shows DEB Ulcer Closure, Misses Stroke Endpoint Redasemtide Shows DEB Ulcer Closure, Misses Stroke Endpoint Read Post »
Clinical TrialsFinal MATTERHORN Analysis Confirms Overall Survival Benefit With Durvalumab... Final MATTERHORN Analysis Confirms Overall Survival Benefit With Durvalumab... Read Post »
Clinical TrialsSetmelanotide Shows BMI and Metabolic Benefits in Paediatric Hypothalamic O... Setmelanotide Shows BMI and Metabolic Benefits in Paediatric Hypothalamic O... Read Post »
Clinical TrialsAtogepant Cuts Menstrual Migraine Days in Phase 3 LUNA Study Atogepant Cuts Menstrual Migraine Days in Phase 3 LUNA Study Read Post »
Clinical TrialsTNP-2092 Shows 100% Six-Month Success in Phase IIa Non-Surgical PJI Trial TNP-2092 Shows 100% Six-Month Success in Phase IIa Non-Surgical PJI Trial Read Post »
Clinical TrialsFDA Pauses New Enrollment in Biohaven’s Opakalim Epilepsy Program Over Ro... FDA Pauses New Enrollment in Biohaven’s Opakalim Epilepsy Program Over Ro... Read Post »
Clinical TrialsOpus Genetics Reports Visual Function Gains with OPGx-BEST1 in Phase 1/2 BE... Opus Genetics Reports Visual Function Gains with OPGx-BEST1 in Phase 1/2 BE... Read Post »
Clinical TrialsTT-P34 Phase 1 Trial Shows CNS Exposure in Parkinson’s TT-P34 Phase 1 Trial Shows CNS Exposure in Parkinson’s Read Post »
Clinical TrialsVOXZOGO (Vosoritide) Shows Significant Growth Improvements in Phase 3 Hypoc... VOXZOGO (Vosoritide) Shows Significant Growth Improvements in Phase 3 Hypoc... Read Post »
Clinical TrialsNeflamapimod Biomarker Data Set to Shed Light on Tau-Driven FTD in Phase 2a... Neflamapimod Biomarker Data Set to Shed Light on Tau-Driven FTD in Phase 2a... Read Post »
Clinical TrialsDISC-3405 Reduces Phlebotomy and Controls Hematocrit in Phase 2 Polycythemi... DISC-3405 Reduces Phlebotomy and Controls Hematocrit in Phase 2 Polycythemi... Read Post »
Clinical TrialsBeeline’s Afimetoran Meets Phase 2 Endpoint in SLE Beeline’s Afimetoran Meets Phase 2 Endpoint in SLE Read Post »
Clinical TrialsFate Advances iPSC-Derived CAR T Pipeline With New Lupus Data Fate Advances iPSC-Derived CAR T Pipeline With New Lupus Data Read Post »
Clinical TrialsEvommune Discontinues EVO756 in Atopic Dermatitis After Earlier CSU Setback Evommune Discontinues EVO756 in Atopic Dermatitis After Earlier CSU Setback Read Post »
Clinical TrialsCOMP360 Shows 52-Week Benefit in Treatment-Resistant Depression COMP360 Shows 52-Week Benefit in Treatment-Resistant Depression Read Post »
Clinical TrialsDabogratinib Posts Promising 79% Response Rate in Phase 2 Results in Bladde... Dabogratinib Posts Promising 79% Response Rate in Phase 2 Results in Bladde... Read Post »
Clinical TrialsSpyre’s SPY003 Delivers a Strong Phase 2 Signal in Ulcerative Colitis Spyre’s SPY003 Delivers a Strong Phase 2 Signal in Ulcerative Colitis Read Post »
Clinical TrialsDeucrictibant XR Shows 83% Reduction in HAE Attacks Deucrictibant XR Shows 83% Reduction in HAE Attacks Read Post »
Clinical TrialsArlo-cel Shows Strong Results in Hard-to-Treat Multiple Myeloma Arlo-cel Shows Strong Results in Hard-to-Treat Multiple Myeloma Read Post »
Clinical TrialsNovartis’ RNA Therapy Del-desiran Stumbles in Phase 3 DM1 Trial Novartis’ RNA Therapy Del-desiran Stumbles in Phase 3 DM1 Trial Read Post »
Clinical TrialsIMDELLTRA Plus Imfinzi Improves Survival in ES-SCLC IMDELLTRA Plus Imfinzi Improves Survival in ES-SCLC Read Post »
Clinical TrialsMosliciguat Demonstrates Strong Hemodynamic and Functional Efficacy in Phas... Mosliciguat Demonstrates Strong Hemodynamic and Functional Efficacy in Phas... Read Post »
Clinical TrialsCS-101 Base Editing Shows Results in SCD and β-Thalassemia CS-101 Base Editing Shows Results in SCD and β-Thalassemia Read Post »
Clinical TrialsUCB Presents Fenfluramine Data in Rare Epilepsies at EEC 2026 UCB Presents Fenfluramine Data in Rare Epilepsies at EEC 2026 Read Post »
Clinical TrialsResomelagon Shows Clearer Efficacy Signal in Post-Hoc Rheumatoid Arthritis ... Resomelagon Shows Clearer Efficacy Signal in Post-Hoc Rheumatoid Arthritis ... Read Post »
Clinical Trials Disease & Drugs“Rentosertib May Be Testing the Next Big Idea in Aging: Can a Disease Dru... “Rentosertib May Be Testing the Next Big Idea in Aging: Can a Disease Dru... Read Post »
Clinical TrialsSemaglutide Shows Promising BMI Reduction as 40.4% of Children Leave Obesit... Semaglutide Shows Promising BMI Reduction as 40.4% of Children Leave Obesit... Read Post »
Clinical TrialsClover’s RSV Vaccines Show Strong Phase 2 Results in Older Adults Clover’s RSV Vaccines Show Strong Phase 2 Results in Older Adults Read Post »
Clinical TrialsKylo-11 Cuts Lipoprotein(a) by Up to 97% After a Single Dose, Sustaining Ef... Kylo-11 Cuts Lipoprotein(a) by Up to 97% After a Single Dose, Sustaining Ef... Read Post »
Clinical TrialsNovartis’ Pelacarsen Fails Phase III Cardiovascular Outcomes Trial Novartis’ Pelacarsen Fails Phase III Cardiovascular Outcomes Trial Read Post »
Clinical TrialsTislelizumab Plus Chemotherapy Shows Sustained Survival in ESCC Tislelizumab Plus Chemotherapy Shows Sustained Survival in ESCC Read Post »
Clinical TrialsArgo Biopharma’s BW-20805 Cuts HAE Attack Rates by Up to 96% in Phase II ... Argo Biopharma’s BW-20805 Cuts HAE Attack Rates by Up to 96% in Phase II ... Read Post »
Clinical TrialsNEJM Publishes Daraxonrasib Phase 1/2 Data in RAS-Mutant NSCLC NEJM Publishes Daraxonrasib Phase 1/2 Data in RAS-Mutant NSCLC Read Post »
Clinical TrialsRoche’s Vabysmo Sustains Vision Gains and Extends Dosing in Asian PCV Pat... Roche’s Vabysmo Sustains Vision Gains and Extends Dosing in Asian PCV Pat... Read Post »
Clinical TrialsOral Gepotidacin Matches Ceftriaxone in NAAT Analysis of Phase 3 Gonorrhea ... Oral Gepotidacin Matches Ceftriaxone in NAAT Analysis of Phase 3 Gonorrhea ... Read Post »
Clinical TrialsBoehringer Ingelheim Announces Nerandomilast Phase 3 IIM Trial Boehringer Ingelheim Announces Nerandomilast Phase 3 IIM Trial Read Post »
Clinical TrialsClimb Bio CLYM116 Shows Durable APRIL Suppression in IgAN Climb Bio CLYM116 Shows Durable APRIL Suppression in IgAN Read Post »
Clinical TrialsEtentamig Shows Promising Results in Phase 3 CERVINO Trial for Multiple Mye... Etentamig Shows Promising Results in Phase 3 CERVINO Trial for Multiple Mye... Read Post »
Clinical TrialsIvonescimab Shows Overall Survival Benefit in Phase III HARMONi-2 NSCLC Tri... Ivonescimab Shows Overall Survival Benefit in Phase III HARMONi-2 NSCLC Tri... Read Post »
Clinical TrialsApazunersen Fails Phase 3 Aspire Trial in Angelman Syndrome Apazunersen Fails Phase 3 Aspire Trial in Angelman Syndrome Read Post »
Clinical TrialsIfebemtinib Plus Garsorasib Shows Promising Activity in KRAS G12C-Mutant Me... Ifebemtinib Plus Garsorasib Shows Promising Activity in KRAS G12C-Mutant Me... Read Post »
Clinical TrialsCamrelizumab-Rivoceranib Improves Survival Across Age Groups in Unresectabl... Camrelizumab-Rivoceranib Improves Survival Across Age Groups in Unresectabl... Read Post »
Clinical TrialsTeva’s TEV ‘408 Shows Positive Phase 2a Celiac Disease Results Teva’s TEV ‘408 Shows Positive Phase 2a Celiac Disease Results Read Post »
Clinical TrialsPlixorafenib Shows Positive Interim Results in BRAF Fusion Tumors Plixorafenib Shows Positive Interim Results in BRAF Fusion Tumors Read Post »
Clinical TrialsRezatapopt Shows Promising 46% Response Rate in Ovarian Cancer Rezatapopt Shows Promising 46% Response Rate in Ovarian Cancer Read Post »
Clinical TrialsNovartis Remibrutinib Shows Strong Phase 3 Results in Multiple Sclerosis Novartis Remibrutinib Shows Strong Phase 3 Results in Multiple Sclerosis Read Post »
Clinical TrialsTagrisso Plus Orpathys Improves Progression-Free Survival in First-Line MET... Tagrisso Plus Orpathys Improves Progression-Free Survival in First-Line MET... Read Post »
Clinical TrialsNirmatrelvir–Ritonavir Fails to Improve Long COVID in Large Phase 2 RECOV... Nirmatrelvir–Ritonavir Fails to Improve Long COVID in Large Phase 2 RECOV... Read Post »
Clinical TrialsArrowhead’s Plozasiran Cuts Triglycerides Up to 81% and Reduces Pancreati... Arrowhead’s Plozasiran Cuts Triglycerides Up to 81% and Reduces Pancreati... Read Post »
